Precision Biosensor (A335810) Stock Overview
Engages in the development, production, and sale of immune diagnostic kits in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A335810 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Precision Biosensor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,442.00 |
| 52 Week High | ₩3,505.00 |
| 52 Week Low | ₩1,341.00 |
| Beta | 0.33 |
| 1 Month Change | -16.74% |
| 3 Month Change | -36.19% |
| 1 Year Change | -52.09% |
| 3 Year Change | -76.05% |
| 5 Year Change | -91.37% |
| Change since IPO | -95.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| A335810 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -4.8% | -4.4% | -4.3% |
| 1Y | -52.1% | -15.0% | 146.8% |
Return vs Industry: A335810 underperformed the KR Medical Equipment industry which returned -15% over the past year.
Return vs Market: A335810 underperformed the KR Market which returned 146.8% over the past year.
Price Volatility
| A335810 volatility | |
|---|---|
| A335810 Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 9.3% |
| 10% most volatile stocks in KR Market | 16.7% |
| 10% least volatile stocks in KR Market | 4.9% |
Stable Share Price: A335810 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A335810's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 98 | Han-Shin Kim | precision-bio.com |
Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
Precision Biosensor, Inc. Fundamentals Summary
| A335810 fundamental statistics | |
|---|---|
| Market cap | ₩31.65b |
| Earnings (TTM) | -₩7.87b |
| Revenue (TTM) | ₩22.34b |
Is A335810 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A335810 income statement (TTM) | |
|---|---|
| Revenue | ₩22.34b |
| Cost of Revenue | ₩14.30b |
| Gross Profit | ₩8.04b |
| Other Expenses | ₩15.91b |
| Earnings | -₩7.87b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -358.73 |
| Gross Margin | 35.98% |
| Net Profit Margin | -35.25% |
| Debt/Equity Ratio | 30.3% |
How did A335810 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/07 03:17 |
| End of Day Share Price | 2026/07/07 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Precision Biosensor, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.